We are excited to announce that Star Therapeutics has successfully raised $90 million in its latest funding round, a significant milestone that underscores our commitment to advancing medical practice and innovation. Based in Lakewood, New Jersey, Star Therapeutics is dedicated to revolutionizing the healthcare landscape by developing cutting-edge therapeutic solutions aimed at improving patient outcomes. This influx of capital will enable us to accelerate our research initiatives, invest in state-of-the-art technology, and expand our clinical trials program. We believe that through these strategic investments, we will enhance our capacity to bring new and effective therapeutics to the market, fulfilling our mission of providing high-quality, evidence-based care to those in need. As we move forward, our team is more motivated than ever to harness this funding to not only enhance our existing offerings but also to explore new frontiers in treatment modalities. Our focus remains on patient-centered care, and we are committed to translating our innovative research into tangible benefits for the communities we serve. As we embark on this exciting journey, we extend our heartfelt gratitude to our investors for their confidence in our vision and our ability to deliver on it. Together, we look forward to shaping the future of therapeutic advancements and making a lasting impact on healthcare. Stay tuned for more updates on our progress, as we strive to create transformative solutions for patients and healthcare providers alike.
Star Therapeutics Secures $90M in Series C Funding to Drive Medical Innovation
Recently funded 路 $90.0M Series cMedical Practices
Get the full Star Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series c rounds
Companies that recently closed a Series c round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  SOLIVIS | Series c | $16.0M | 1d ago |
| 2 |  SKAN Switzerland | Series c | $63.0M | 1d ago |
| 3 |
